Replimune Group, Inc. (REPL) vs Vor Biopharma Inc. (VOR)

Replimune Group, Inc. and Vor Biopharma Inc. are both Biotechnology companies. Replimune Group, Inc. is the larger, with a market value of $1.2B against $1.1B — 1.1× the size. Across the 10 metrics below, Vor Biopharma Inc. leads on 7 and Replimune Group, Inc. on 3.

Valuation

Metric REPL VOR Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 11.37 7.16 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (25.40%) (2,046.98%) (28.84%)
Free cash flow yield (23.36%) (7.56%) (23.03%)

Profitability

Metric REPL VOR Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (134.29%) (69.27%) (57.72%)
Return on assets (82.28%) 0.00% (49.22%)
Return on invested capital (1,154.69%) 0.00% 0.00%

Growth

Metric REPL VOR Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (10.10%) (107.35%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric REPL VOR Biotechnology median
Debt to equity 1.00 0.21 0.00
Current ratio 5.23 10.69 4.73
Net debt to EBITDA 0.51 2.27 0.96

Dividend

Metric REPL VOR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric REPL VOR Biotechnology median
Market cap 1.20b 1.09b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack